Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Anadys Pharmaceuticals Provides Progress Update On Phase II Study Of ANA598 In Hepatitis C Patients
Anadys Pharmaceuticals Provides Progress Update On Phase II Study Of ANA598 In Hepatitis C Patients
Anadys Pharmaceuticals Provides Progress Update On Phase II Study Of ANA598 In Hepatitis C Patients
Submitted by
admin
on January 23, 2010 - 11:29am
Source:
Medical News Today
News Tags:
Anadys
hepatitis C
Headline:
Anadys Pharmaceuticals Provides Progress Update On Phase II Study Of ANA598 In Hepatitis C Patients
Do Not Allow Advertisers to Use My Personal information
